(Q38927587)
Statements
1 reference
A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer (English)
1 reference
Youli Pan
Mingwu Zheng
Lei Zhong
Jiao Yang
Shu Zhou
Ya Qin
Rong Xiang
17 December 2014
1 reference
1 reference